These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19300249)

  • 1. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
    Kaul M
    Curr Opin Neurol; 2009 Jun; 22(3):315-20. PubMed ID: 19300249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Wright EJ
    Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.
    Yuan NY; Kaul M
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated neurocognitive disorders (HAND).
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
    Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
    Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
    Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).
    Xia C; Luo D; Yu X; Jiang S; Liu S
    Microbes Infect; 2011 May; 13(5):419-25. PubMed ID: 21262373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.
    Peluso MJ; Spudich S
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.
    Clark US; Cohen RA
    Curr Opin Investig Drugs; 2010 Aug; 11(8):884-900. PubMed ID: 20721831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
    Lindl KA; Marks DR; Kolson DL; Jordan-Sciutto KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):294-309. PubMed ID: 20396973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective therapy for HIV dementia.
    Turchan J; Sacktor N; Wojna V; Conant K; Nath A
    Curr HIV Res; 2003 Oct; 1(4):373-83. PubMed ID: 15049424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?
    Vissers M; Stelma FF; Koopmans PP
    J Clin Virol; 2010 Dec; 49(4):231-8. PubMed ID: 20833583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological frontiers in the treatment of AIDS dementia.
    McGuire D; Marder K
    J Psychopharmacol; 2000; 14(3):251-7. PubMed ID: 11106304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.
    Ances BM; Clifford DB
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):455-61. PubMed ID: 18957181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of HIV-associated neurocognitive disorders pathogenesis.
    Gannon P; Khan MZ; Kolson DL
    Curr Opin Neurol; 2011 Jun; 24(3):275-83. PubMed ID: 21467932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 infection and neurocognitive impairment in the current era.
    del Palacio M; Alvarez S; Muñoz-Fernández MÁ
    Rev Med Virol; 2012 Jan; 22(1):33-45. PubMed ID: 21990255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions.
    Swindells S; Zheng J; Gendelman HE
    AIDS Patient Care STDS; 1999 Mar; 13(3):153-63. PubMed ID: 10375263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.
    Navia BA; Rostasy K
    Neurotox Res; 2005 Oct; 8(1-2):3-24. PubMed ID: 16260383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating HIV Infection in the Central Nervous System.
    Calcagno A; Di Perri G; Bonora S
    Drugs; 2017 Feb; 77(2):145-157. PubMed ID: 28070871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-associated neurocognitive disorders: perspective on management strategies.
    Nabha L; Duong L; Timpone J
    Drugs; 2013 Jun; 73(9):893-905. PubMed ID: 23733447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.